RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+41.87%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$1.39B
AUM Growth
+$1.39B
(+32%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
9.92%
Top 10 Holdings %
Top 10 Hldgs %
75.78%
Holding
46
New
8
Increased
24
Reduced
6
Closed
6
Top Buys
| 1 |
Arrowhead Research
ARWR
|
$73.2M |
| 2 |
Sarepta Therapeutics
SRPT
|
$38.4M |
| 3 |
LivaNova
LIVN
|
$29M |
| 4 |
Qiagen
QGEN
|
$19.1M |
| 5 |
Regenxbio
RGNX
|
$14.5M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$29.2M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$22.1M |
| 3 |
Edwards Lifesciences
EW
|
$20.3M |
| 4 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$14M |
| 5 |
Bristol-Myers Squibb
BMY
|
$10.7M |
Sector Composition
| 1 | Healthcare | 94.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
electroCore
ECOR
$38.8M
| $8.34M | 0.6% |
+33,700
| New | +$8.34M |
|
|
NVTR
27
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $7.86M | 0.57% |
383,030
-124,031
| -24% | -$2.55M |
|
|
VIVE
28
DELISTED
VIVEVE MED INC
VIVE
| $7.78M | 0.56% |
2,861
+303
| +12% | +$824K |
|
|
ODT
29
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $6.1M | 0.44% |
276,368
+1,824
| +0.7% | +$40.3K |
|
30
Neuronetics
STIM
$216M
| $5.06M | 0.36% |
+190,000
| New | +$5.06M |
|
31
Q32 Bio
QTTB
$20.9M
| $4.62M | 0.33% |
12,580
+80
| +0.6% | +$29.4K |
|
32
Novavax
NVAX
$1.2B
| $3.54M | 0.26% |
132,217
-4,108
| -3% | -$110K |
|
|
KA
33
DELISTED
Kineta, Inc. Common Stock
KA
| $3.01M | 0.22% |
7,696
-196
| -2% | -$76.6K |
|
34
argenx
ARGX
$44.2B
| $2.12M | 0.15% |
25,559
+102
| +0.4% | +$8.45K |
|
35
Eledon Pharmaceuticals
ELDN
$155M
| $2.11M | 0.15% |
16,767
+100
| +0.6% | +$12.6K |
|
36
Marker Therapeutics
MRKR
$11.2M
| $1.89M | 0.14% |
+20,000
| New | +$1.89M |
|
|
BLCM
37
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.11M | 0.08% |
+15,029
| New | +$1.11M |
|
38
Adverum Biotechnologies
ADVM
$68.2M
| $935K | 0.07% |
17,637
+116
| +0.7% | +$6.15K |
|
|
MOTS
39
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $428K | 0.03% |
198
-197
| -50% | -$426K |
|
|
40
Edwards Lifesciences
EW
$47.7B
| – | – |
-435,738
| Closed | -$20.3M |
|
41
OraSure Technologies
OSUR
$230M
| – | – |
-117,291
| Closed | -$1.98M |
|
|
GBT
42
DELISTED
Global Blood Therapeutics, Inc.
GBT
| – | – |
-456,921
| Closed | -$22.1M |
|
|
ARMO
43
DELISTED
ARMO BioSciences, Inc. Common Stock
ARMO
| – | – |
-413,892
| Closed | -$14M |
|
|
AVXS
44
DELISTED
AveXis, Inc. Common Stock
AVXS
| – | – |
-236,425
| Closed | -$29.2M |
|